"The Tour seems to be missing the key component of an affective testing program--transparency."

Rex Hoggard at GolfChannel.com explains why the revelation of Bhavik Patel's PED violation was not only unsatisfactory, but strangely lacking in the primary detail: what PED was used.

Since we learned that information in the Doug Barron case, why not in this one?

Although the Tour’s original PED manual in 2008 stated, "... the PGA Tour will, at a minimum, publish the name of the player, the anti-doping rule violation, and the sanction imposed,” for a performance-enhancing violation, that policy was amended in January 2009 when “the anti-doping violation” wording was removed from the policy.

However subtle the reworded policy may seem, it only serves to further extend a cloak of secrecy that has defined the anti-doping program since its inception.